Quality and safety of Chinese herbal medicines guided by a systems biology perspective

被引:142
作者
Wang, Jiangshan [3 ,4 ,7 ]
van der Heijden, Rob [4 ]
Spruit, Shannon [1 ,2 ]
Hankermeier, Thomas [4 ]
Chan, Kelvin [5 ,6 ]
van der Greef, Jan [1 ,2 ,4 ,7 ]
Xu, Guowang [3 ,7 ]
Wang, Mei [1 ,2 ,7 ]
机构
[1] SU BioMed, NL-3700 AJ Zeist, Netherlands
[2] TNO, Qual Life, NL-3700 AJ Zeist, Netherlands
[3] Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Separat Sci Analyt Chem, Dalian 116023, Peoples R China
[4] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Analyt Biosci, NL-2300 RA Leiden, Netherlands
[5] Wolverhampton Univ, Sch Appl Sci, Res Inst Healthcare Sci, Wolverhampton WV1 1LY, England
[6] Wolverhampton Univ, Dept Pharm, Wolverhampton WV1 1LY, England
[7] Sino Dutch Ctr Prevent & Personalized Med, NL-3700 AJ Zeist, Netherlands
关键词
Chinese materia medica; Systems biology; Systems toxicology; Metabolomics; Aconitum roots; SEVERE MYOCLONIC EPILEPSY; MASS-SPECTROMETRY; DRUG SAFETY; ARISTOLOCHIC ACID; FIELD-DESORPTION; ACONITUM; TOXICITY; ALKALOIDS; PHARMACOLOGY; MUTATIONS;
D O I
10.1016/j.jep.2009.07.040
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
Chinese herbal medicines, often referred as Chinese materia medica (CMM), are comprised of a complex multicomponent nature. The activities are aimed at the system level via interactions with a Multitude of targets in the human body. This review aims at the toxicity aspects of CMM and its preparations at the different steps of production; harvesting, processing and the final formulation. The historic perspective and today's issues of the safety of CMM are introduced briefly, followed by the descriptions of the toxic CMM in the Current Chinese Pharmacopoeia (2005). subsequently, several aspects of safety are illustrated using a typical example of a toxic CMM, Aconitum roots, and some recent findings of our Own research are included to illustrate that proper processing and multi-herbs formulation can reduce the level of toxic components. This also explains that in CMM, some herbs, Such as Aconitum, Ephedra species are never used as single herb for intervention and that aconite is only used when it is processed and in combination with specific matched other herbs. The formulation principle of multi-herbs intervention strategy is a systems approach for the treatment and prevention of disease. In this light, the role of systems toxicology in the safety and quality of Chinese herbal medicine is proposed as a promising method. Moreover the principles of practiced-based and evidence-based research are discussed from a symbiotic perspective. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:31 / 41
页数:11
相关论文
共 63 条
[1]
Correlation network analysis for data integration and biomarker selection [J].
Adourian, Aram ;
Jennings, Ezra ;
Balasubramanian, Raji ;
Hines, Wade M. ;
Damian, Doris ;
Plasterer, Thomas N. ;
Clish, Clary B. ;
Stroobant, Paul ;
McBurney, Robert ;
Verheij, Elwin R. ;
Bobeldijk, Ivana ;
Van der Greef, Jan ;
Lindberg, Johan ;
Kenne, Kerstin ;
Andersson, Ulf ;
Hellmold, Heike ;
Nilsson, Kerstin ;
Salter, Hugh ;
Schuppe-Koistinen, Ina .
MOLECULAR BIOSYSTEMS, 2008, 4 (03) :249-259
[2]
The effects of Aconitum alkaloids on the central nervous system [J].
Ameri, A .
PROGRESS IN NEUROBIOLOGY, 1998, 56 (02) :211-235
[3]
[Anonymous], 2005, Pharmacopoeia of thePeople's Republic of China
[4]
Risks associated with the practice of traditional Chinese medicine -: An Australian study [J].
Bensoussan, A ;
Myers, SP ;
Carlton, AL .
ARCHIVES OF FAMILY MEDICINE, 2000, 9 (10) :1071-1078
[5]
[6]
Clinical correlations of mutations in the SCN1A gene:: From febrile seizures to severe myoclonic epilepsy in infancy [J].
Ceulemans, BPGM ;
Claes, LRF ;
Lagae, LG .
PEDIATRIC NEUROLOGY, 2004, 30 (04) :236-243
[7]
Chinese medicinal materials and their interface with Western medical concepts [J].
Chan, K .
JOURNAL OF ETHNOPHARMACOLOGY, 2005, 96 (1-2) :1-18
[8]
CHAN K, 2000, INTERACTIONS CHINESE
[9]
Chan Kelvin., 2002, WAY FORWARD CHINESE
[10]
A multidisciplinary approach to the toxicologic problems associated with the use of herbal medicines [J].
Chan, TYK ;
Tam, HP ;
Lai, CK ;
Chan, AYW .
THERAPEUTIC DRUG MONITORING, 2005, 27 (01) :53-57